AIM vs VRTX: Which Stock is Better?
Side-by-side comparison of Aim Immunotech Inc and Vertex Pharmaceuticals Inc in 2026
AIM
Aim Immunotech Inc
$0.69
VRTX
Vertex Pharmaceuticals Inc
$477.89
Key Metrics Comparison
| Metric | AIM | VRTX | Winner |
|---|---|---|---|
| Market Cap | $2.79M | $120.46B | VRTX |
| P/E Ratio | N/A | 30.96 | VRTX |
| EPS (TTM) | $N/A | $15.32 | VRTX |
| Revenue Growth | -0.3% | 0.1% | VRTX |
| Gross Margin | 15.2% | 53.7% | VRTX |
Analyze AIM
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AIM or VRTX a better investment?
Comparing AIM and VRTX: Aim Immunotech Inc has a market cap of $2.79M while Vertex Pharmaceuticals Inc has $120.46B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AIM and VRTX?
AIM (Aim Immunotech Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AIM or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AIM or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.3% for AIM.
Which company is more profitable: AIM or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 15.2% for AIM.
Which is the larger company: AIM or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $120.46B compared to $2.79M for AIM.
Should I buy AIM or VRTX in 2026?
Both AIM and VRTX have investment merit. AIM trades at $0.69 while VRTX trades at $477.89. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AIM and VRTX stock?
Key differences: Market Cap ($2.79M vs $120.46B), P/E Ratio (N/A vs 31.0x), Revenue Growth (-0.3% vs 0.1%), Gross Margin (15.2% vs 53.7%).